Inghams shares have been volatile in the last 12 months, but better times might be ahead
It has been a while since we last wrote about Inghams shares (ASX:ING) – 8 months to be exact. It…
Read More
Its reporting season in New Zealand in May and these 5 ASX companies are about to report annual results
Its always reporting season in New Zealand in May as well as November, because many companies there follow an April…
Read More
Immutep (ASX:IMM): Set to commercialise its lung cancer treatment by 2027
Developing a cancer drug is a long journey, but Immutep (ASX:IMM) is more towards the end than the start. A…
Read More